BIOMAT Database Logo BIOMAT Database Logo

Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists. 1993

H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
Department of Chemistry, Searle R&D, St. Louis, Missouri 63198.

2,5-Dibutyl-2,4-dihydro-4-[[2-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4' - yl]methyl]-3H-1,2,4-triazol-3-one, SC-51316, was synthesized as a potent and orally active angiotensin II (AII) receptor antagonist with a long duration of action. To explore the lipophilic pocket in the AII receptor interacting with the substituent at the 2-position of triazolone-based antagonists, a series of compounds were prepared and evaluated for receptor binding affinity and antagonism of AII-contracted rabbit aortic rings. It has been found that the pocket is very spacious and can accommodate different sizes of lipophilic groups and various functionalities. Acidic groups generally result in a slight decrease in binding affinity. Branched chains are unfavorable. The freedom of rotation around C2-C3 in the flexible side chain is crucial for good binding. The 2-phenylethyl-substituted triazolone analogue exhibits the highest in vitro potency among all compounds that have been synthesized.

UI MeSH Term Description Entries
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013777 Tetrazoles
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D014599 Uterus The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES. Fundus Uteri,Uteri,Uterine Cornua,Uterine Fundus,Uterus Cornua,Womb,Cornua, Uterine,Fundus Uterus,Fundus, Uterine,Uteri, Fundus,Wombs

Related Publications

H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.
December 1993, Journal of medicinal chemistry,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
June 1993, Journal of medicinal chemistry,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.
August 1993, Journal of medicinal chemistry,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives.
March 1992, Journal of medicinal chemistry,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.
July 1993, Journal of medicinal chemistry,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
Nonpeptide angiotensin II receptor antagonists.
August 1990, American journal of hypertension,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
[Nonpeptide angiotensin II-receptor antagonists].
September 1994, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
[Nonpeptide angiotensin II receptor antagonists].
August 1993, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
Nonpeptide angiotensin II receptor antagonists.
February 1991, Trends in pharmacological sciences,
H C Huang, and D B Reitz, and T S Chamberlain, and G M Olins, and V M Corpus, and E G McMahon, and M A Palomo, and J P Koepke, and G J Smits, and D E McGraw
Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.
May 2008, Peptides,
Copied contents to your clipboard!